Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia

NCT01327014 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: XueZhiKang (XZK), a botanic product with multiple components
DRUG: Placebo

Sponsor

Beijing Peking University WBL Biotech Co., Ltd.